ADVFN Logo
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

REGN34 Regeneron Pharmaceuticals Inc

89.55
0.55 (0.62%)
Last Updated: 15:54:54
Delayed by 15 minutes

Income Statement

Balance Sheet

Cash Flow

Quarter End Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)
Total Revenue 2.87B2.98B3.42B3.16B3.16B3.36B3.43B3.15B
Operating Income 1.18B1.26B1.05B946.7M1.02B1.11B972.9M751.4M
Pre Tax Income 963.2M1.51B1.32B858M1.08B1.11B1.15B700.7M
Net Income 852.1M1.32B1.2B817.8M968.4M1.01B1.16B722M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) 00000000
EBIT 1.21B1.12B1.1B876M1.03B1.13B920.7M751.5M
EBITDA 1.25B1.35B1.15B1.05B1.12B1.22B1.09B865.5M
Year End December 30 2023 20162017201820192020202120222023
USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)
Total Revenue 4.86B5.87B6.71B7.86B8.78B16.12B12.26B13.12B
Operating Income 1.33B2.08B2.53B2.21B3.58B8.95B4.74B4.05B
Pre Tax Income 1.33B2.08B2.55B2.43B3.81B9.33B4.86B4.2B
Net Income 895.52M1.2B2.44B2.12B3.51B8.08B4.34B3.95B
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) 4.1785.32410.7059.49216.24636.75719.58217.951
EBIT 1.34B2.1B2.58B2.34B3.67B9B4.8B4.03B
EBITDA 1.44B2.22B2.68B2.42B3.81B9.23B5.08B4.47B